Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
A series of low-molecular weight compounds that act as TSH receptor antagonists (inhibitors) or agonists (activators) More
Clinical identification of a new disease termed "isolated micronodular adrenocortical disease" (iMAD), as well as the role of PDE11A gene in this disease More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2011 - 7 pages - $3,835
Jan 2010 - $75
Apr 2011 - 100 pages - $500
Jan 2011 - 12 pages - $99
Jun 2008 - $2,500
Nov 2007 - 53 pages - $495
Aug 2010 - 14 pages - $99
Jan 2011 - 23 pages - $99
Jan 2010 - 24 pages - $99
Jan 2011 - 11 pages - $99
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us